Boston Globe via Associated Press – Continued coverage on the $17.5 million awarded to Dartmouth from the Agency for Healthcare Research and Quality to study how well, and how quickly, hospitals learn from their successes. Quotes Elliott Fisher, director and professor of the Dartmouth Institute for Health Policy and Clinical Practice at Geisel, who will lead the work of nine researchers from Geisel joined by others from Harvard University, the University of California at Berkeley, Intermountain Health Care in Salt Lake City and the Mayo Clinic in Rochester, Minn.
Post Tagged with: "The Dartmouth Institute"
3 North Texas Hospitals Inflate Bills of the Uninsured, National Study Finds
Dallas Morning News – Quotes Jonathan Skinner, professor of community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice at Geisel, and professor of economics at Dartmouth, on a recent study that revealed it is common practice at Texas General and two other for-profit medical centers in North Texas to charge patients upward of nine times the cost of care. While insurance companies and federal health care programs arrange lower prices with hospitals, the uninsured don’t have the same negotiating power and are often left with hefty bills.
Pioneer ACOs: Anatomy Of A ‘Victory’
Health Affairs Blog – References a policy objective for ACOs proposed in Health Affairs in 2007 by Elliott Fisher, director and professor of the Dartmouth Institute for Health Policy and Clinical Practice, and professor of medicine, and community and family medicine, and colleagues from Dartmouth. The policy objective focused on reducing variation in Medicare shared savings rather than containing costs.
Dartmouth Gets Grant to Lead Study on Hospitals
Valley News – Dartmouth will receive $17.5 million over five years from the Agency for Healthcare Research and Quality to study how well, and how quickly, hospitals learn from their successes. Elliott Fisher, director and professor of the Dartmouth Institute for Health Policy and Clinical Practice at Geisel, will lead the work of nine researchers from Geisel joined by others from Harvard University, the University of California at Berkeley, Intermountain Health Care in Salt Lake City and the Mayo Clinic in Rochester, Minn.
Dartmouth Named National Center of Excellence to Study Health Care Delivery and Outcomes
Dartmouth has been named one of three National Centers of Excellence by the Agency for Healthcare Research and Quality (AHRQ) to study health care delivery and patient outcomes.
Balancing Goals in The MSSP: Consider Variable Savings Rates
Health Affairs Blog – A blog post written by Carrie Colla, assistant professor of the Dartmouth Institute for Health Policy and Clinical Practice at Geisel; Elliott Fisher, director and professor of the Dartmouth Institute for Health Policy and Clinical Practice at Geisel; Scott Heiser, policy analyst; and Emily Tierny, health policy fellow. In the post, they examine the Centers for Medicare and Medicaid Services’ recent changes to the Medicare Shared Savings Program, and accountable care organization’s (ACO) concerns about how the financial targets, which determine whether an ACO is successful at saving or guilty of overspending, are determined under the new requirements.
How Apple and Google Are Going to Help Cure Humanity’s Diseases
Huffington Post – Quotes Lisa Schwartz, professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice at Geisel, on Apple’s new open-platform medical research tool ResearchKit.
Is It Low-T? No It’s Big Pharma Peddling a Nonexistent Disease
Valley News via Washington Post – Continued coverage of an opinion piece by Steven Woloshin and Lisa Schwartz, both professors of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice at Geisel, on how the Food and Drug Administration is pushing back against the over-prescribing of testosterone.
Sell a disease to sell a drug
Washington Post – An opinion piece by Steven Woloshin and Lisa Schwartz, both professors of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice at Geisel, on how the Food and Drug Administration is pushing back against the over-prescribing of testosterone.
Are Your Patients Monitoring You?
Health IT Outcomes – Quotes Glyn Elwyn, professor of community and family medicine and of the Dartmouth Institute for Health Policy and Clinical Practice at Geisel, on the recent trend of patients recording interactions with their physicians during visits to the doctors office.